Worldwide laxative business by 2028

Dublin, February 22, 2021 (GLOBE NEWSWIRE) – The report “Laxatives Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecast, 2020-2028” has been added ResearchAndMarkets.com Offer.

The global laxative market is growing significantly and is projected to grow 5.5% over the estimated period from 2020 to 2028, starting at $ 5,462.9 million in 2019.

Constipation is one of the most common conditions diagnosed in clinical practice. Up to a fifth of the general population suffers from chronic constipation. Certain studies have reported a prevalence of 24% to 50% in older adults. It is also observed that between 10% and 18% of community housing geriatrics and 74% of nursing home residents use laxatives on a regular basis. Constipation can have a significant impact on patients’ everyday functions and quality of life. Severe cases of constipation can also lead to coronary episodes, cerebral ischemia, and syncope. To alleviate the complications caused by uncontrolled or untreated constipation, these patients are often prescribed various types of laxatives, especially those belonging to the older age group.

Constipation can be treated with home remedies such as fiber, regular exercise, and increased fluid intake. Home remedies are effective in treating mild constipation cases. However, laxatives are the drugs that are used to treat severe and mild constipation cases. These laxatives have different mechanisms for curing constipation and vary from drug to drug. Classes of drugs, including psyllium and methyl cellulose, increase stool mass and produce an outcome that causes bowel movement. Therefore, these classes of active ingredients are also known as mass-building laxatives. Additionally, some drugs work by accumulating the volume of water in the stool, which makes the stool looser and easier to pass. Medicinal compounds like senna and bisacodyl are known to be stimulant laxatives. Stimulant laxatives work by inducing a bowel movement by speeding up the movement of the colon muscles.

Additionally, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more people staying at home. Hence, a sedentary lifestyle has led to the development of chronic constipation. In addition, the increasing demand for junk food drastically changes the peristaltic activity of the bowel and leads to hardening of the stool. Hence, the laxative market is expected to see significant growth in the forecast period from 2020 to 2028.

Regional analysis:

In 2019, North America dominated the regional laxative market. Because of the strong existence of all major Rx and OTC laxatives, greater awareness of constipation and how to treat it quickly are the main factors contributing to the standout not only of laxatives but the overall digestive drug market in North America. The presence of important market participants such as Bayer AG, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Plc. and others continue to support the positive market growth in the region.

The Asia-Pacific region is expected to be the fastest growing region over the forecast period due to the increasing geriatric pool with altered peristaltic bowel activity. In addition, the steady rise in the sedentary lifestyle and the growing propensity to consume fast food will continue to fuel market growth in the Asia-Pacific region.

This report is an in-depth research study of the global Laxatives market, which brings out key market trends based on quantitative and qualitative research. This report provides detailed description of the global Laxative Market segments by drug types and geographic location. This report will assist the market players in making better decisions and strategies in the laxatives market.

Historical & forecast period:

This study report presents an analysis for each segment from 2018 to 2028, taking 2019 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments, estimated for the forecast period from 2020 to 2028.

The current report also covers qualitative and qualitative market assessment factors such as key market drivers, market trends, restraints, and opportunities that enable a better market understanding of the overall laxative market. Additionally, the global report provides a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.

Key questions answered in this report:

The story goes on

  • What are the current market trends and dynamics in the laxative market and what are the valuable opportunities for emerging players?

  • Which segment has the fastest CAGR in the forecast period?

  • What are the drivers of the laxative market?

  • Notable developments in the laxative market.

  • What is the market trend and dynamism in emerging markets such as Asia-Pacific, Latin America, and the Middle East and Africa?

  • A comparison scenario for all segments for the years 2019 (current) and 2028 (forecast)

Main topics covered:

Chapter 1. Preface
1.1. Report scope and description
1.2. Research methodology
1.2.1. Phase I desk research
1.2.2. Phase II primary research
1.2.3. Phase III expert panel review
1.2.4. Assumptions
1.2.5. Approach adopted

Chapter 2. Summary
2.1. Global Laxatives Market Portraiture
2.2. Global Laxatives Market, by Drug Type, 2019 (in MILLION USD)
2.3. Global Laxatives Market, by Geography, 2019 (in MILLION USD)

Chapter 3. Laxative Market Analysis
3.1. Laxative Market Review
3.2. Market dynamics
3.2.1. Market leader
3.2.1.1. Lifestyle trends increase the risk of constipation and thus the consumption of laxatives
3.2.1.2. Higher prevalence of constipation in the geriatric population
3.2.2. Challenges
3.2.2.1. Demographic reservations about influencing the market
3.2.3. opportunities
3.2.3.1. Emerging countries offer lucrative growth opportunities
3.3. Attractive investment offer by geography, 20
3.4. Competitive landscape, from key players, 20

Chapter 4. Global Laxatives Market by Drug Type, 2018-2028 (in MILLION USD)
4.1. Preface
4.1.1. Attractive investment proposal based on drug type, 20
4.2. Senna
4.3. Bisacodyl
4.4. Focus
4.5. Polyethylene glycol 33
4.6. Flea seeds
4.7. Methyl cellulose
4.8. Other
4.9. Pipeline analysis (market assessments until 2028)

Chapter 5. Global Laxatives Market, By Geography, 2018-2028 (USD MILLION)
5.1. overview
5.2. North America Laxative Market Analysis, 2018-2028 (in MILLION USD)
5.2.1. North America Laxatives Market, By Drug Type, 2018-2028 MILLION)
5.2.2. North America Laxative Market, by Country, 2018-2028 (in MILLION USD)
5.2.2.1. US
5.2.2.2. Canada
5.3. Laxative Market Analysis in Europe, 2018-2028 (in MILLION USD)
5.3.1. Europe Laxatives Market, by Drug Type, 2018-2028 million USD)
5.3.2. Europe Laxatives Market, by Country, 2018-2028 (in MILLION USD)
5.3.2.1. United Kingdom
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia-Pacific Laxative Market Analysis, 2018-2028 (in MILLION USD)
5.4.1. Asia Pacific Laxative Market, By Drug Type, 2018-2028M USD
5.4.2. Asia Pacific Laxative Market, by Country, 2018-2028 (in MILLION USD)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Laxative Market Analysis in Latin America, 2018-2028 (in MILLION USD)
5.5.1. Latin America Laxative Market, By Drug Type, 2018-2028M USD)
5.5.2. Latin America Laxative Market, by Country, 2018-2028 (in MILLION USD)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East and Africa (MEA) Laxative Market Analysis, 2018-2028 (in MILLION USD)
5.6.1. MEA Laxatives Market, By Drug Type, 2018-2028 (In MILLION USD)
5.6.2. MEA Laxatives Market, by Country, 2018-2028 (in MILLION USD)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Bayer AG
6.1.1. Business description
6.1.2. Financial information (subject to data availability)
6.1.3. Application portfolio
6.1.4. Key developments
6.2. Boehringer Ingelheim Pharmaceuticals, Inc.
6.3. Braintree Laboratories, Inc.
6.4. GlaxoSmithKline Consumer Healthcare, LP
6.5. Procter & Gamble Company
6.6. Purdue Pharma LP
6.7. Sucampo Pharmaceuticals, Inc.

Please visit https://www.researchandmarkets.com/r/tlezo2 for more information on this report

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For EST office hours, call 1-917-300-0470. For US / CAN toll free, call 1-800-526-8630. For GMT office hours, call +353-1-416-8900

Comments are closed.